2Kestenbaum B,Gillen DL,Sherrard DJ,et al.Calcium channel blocker use and mortality among patients with end-stage renal disease.Kidney Int,2002,61:2157-2164.
2Sven-,on S.Kjellgren KI.Adverse events and patients perceptions o f antihy pertensive drug effectiveness[J].Journal of Human Hypertension,2003,17(10):671-5.
3Neutel JM.Ambulatory blood pressure monitoring to assess the comparati ve efficacy and duration of a novel new angio-tensin Ⅱ receptor blocker-telmi sartan[J].Blood Prese Suppl,2001,1:27-32.
4Burnier M,Maillard M.The comparative pharmacology of angiotensin Ⅱ r eceptor antagonists[J].Blood Press Suppl,2001,1:6-11.
